Visual outcomes 24 months after LaserACE

• 作者: AnnMarie Hipsley Brad Hall Chi-Chin Sun Daniel Goldberg David Hui-Kang Ma Mitchell A.Jackson
• 来源期刊: 眼视光学杂志(英文版)
• 学科: 医学
• 关键词: PRESBYOPIA ACCOMMODATION Clinical TRIAL Asian EYES Visual ACUITY
• 年，卷（期）: 2018,（2）
• 页码范围: 11-21
• 页数: 11页
• 分类号: R73

摘要

Background:To evaluate the effects on near and intermediate visual performance after bilateral Laser Anterior Ciliary Excision (LaserACE) procedure.Methods:LaserACE surgery was performed using the VisioLite 2.94 μm erbium:yttrium-aluminum-garnet (Er∶YAG) ophthalmic laser system in 4 oblique quadrants on the sclera over the ciliary muscle in 3 critical zones of physiological importance (over the ciliary muscles and posterior zonules) with the aim to improve natural dynamic accommodative forces.LaserACE was performed on 26 patients (52 eyes).Outcomes were analyzed using visual acuity testing,Randot stereopsis,and the CatQuest 9SF patient survey.Results:Binocular uncorrected near visual acuity (UNVA) improved from +0.20 + 0.16 logMAR preoperatively,to +0.12 + 0.14 logMAR at 24 months postoperatively (p =0.0014).There was no statistically significant loss in distance corrected near visual acuity (DCNVA).Binocular DCNVA improved from +0.21 + 0.17 logMAR preoperatively,to +0.11 + 0.12 logMAR at 24 months postoperatively (p =0.00026).Stereoacuity improved from 74.8 + 30.3 s of arc preoperatively,to 58.8 + 22.9 s of arc at 24 months postoperatively (p =0.012).There were no complications such as persistent hypotony,cystoid macular edema,or loss of best-corrected visual acuity (BCVA).Patients surveyed indicated reduced difficulty in areas of near vision,and were overall satisfied with the procedure.Conclusions:Preliminary results of the LaserACE procedure show promising results for restoring visual performance for near and intermediate visual tasks without compromising distance vision and without touching the visual axis.The visual function and visual acuity improvements had clinical significance.Patient satisfaction was high postoperatively and sustained over 24 months.Trial registration:NCT01491360 (https://clinicaltrials.gov/ct2/show/NCT01491360).Registered 22 November 2011.